Company MRI Interventions Inc OTC Bulletin Board
Equities
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biologics and Drug Delivery - Services and License
47.8
%
| 5 | 26.4 % | 11 | 47.8 % | +110.83% |
Functional Neurosurgery Navigation and Therapy - Disposable Products
31.7
%
| 8 | 36.9 % | 8 | 31.7 % | +0.03% |
Biologics and Drug Delivery - Disposable Products
9.0
%
| 4 | 18.0 % | 2 | 9.0 % | -41.63% |
Capital Equipment and Software - Services
4.1
%
| 1 | 3.9 % | 1 | 4.1 % | +22.39% |
Functional Neurosurgery Navigation and Therapy - Services
3.9
%
| 2 | 7.5 % | 1 | 3.9 % | -39.43% |
Capital Equipment and Software - Systems and Software Products
3.6
%
| 2 | 7.4 % | 1 | 3.6 % | -43.12% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 21 | 100.0 % | 24 | 100.0 % | +16.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Burnett
CEO | Chief Executive Officer | 47 | 06/11/17 |
Director of Finance/CFO | 39 | 28/09/20 | |
Mazin Sabra
COO | Chief Operating Officer | 44 | 09/10/22 |
Caroline Corner
IRC | Investor Relations Contact | - | - |
Jeremy Stigall
PRN | Corporate Officer/Principal | 41 | 30/06/20 |
General Counsel | - | 04/04/21 | |
Sales & Marketing | - | 31/10/19 | |
General Counsel | - | - | |
Robert Korn
SAM | Sales & Marketing | 58 | 11/11/12 |
Chris Yelley
PRN | Corporate Officer/Principal | - | 31/12/11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
B. Johnson
BRD | Director/Board Member | 72 | 31/08/19 |
Lynnette Fallon
BRD | Director/Board Member | 64 | 14/07/21 |
R. Fletcher
CHM | Chairman | 78 | 08/05/17 |
Pascal Girin
BRD | Director/Board Member | 64 | 02/09/14 |
Timothy Richards
BRD | Director/Board Member | 66 | 09/03/14 |
Joseph Burnett
CEO | Chief Executive Officer | 47 | 06/11/17 |
Matthew Klein
BRD | Director/Board Member | 52 | 15/04/20 |
Linda Liau
BRD | Director/Board Member | 57 | 01/11/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,420,327 | 25,250,110 ( 92.09 %) | 0 | 92.09 % |
Company contact information
Clearpoint Neuro, Inc.
120 South Sierra Avenue Suite 100
92075, Solana Beach
+
http://www.clearpointneuro.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+4.64% | 208B | |
+8.99% | 182B | |
+29.83% | 155B | |
+35.17% | 115B | |
+2.55% | 66.52B | |
+15.06% | 53.93B | |
-6.47% | 46.26B | |
-2.14% | 38.22B | |
+6.88% | 36.6B |